Stay updated on Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Added Lung cancer tag and related topics, including a link to MedlinePlus Genetics. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-30T16:31:54.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Added a new Locations section featuring Quebec as a study site and removed the Quebec Locations listing. The page version notes show Revision: v3.3.3 added and Revision: v3.3.2 removed.
    Difference
    0.2%
    Check dated 2025-12-23T09:55:11.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The page shows a new revision label, updating from v3.3.1 to v3.3.2, a maintenance/version update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T16:50:38.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Revision label in the page footer changed from v3.2.0 to v3.3.1; no changes to study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T14:00:21.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    Deleted the recurring government funding status notice that warned users information may not be up to date and that inquiries could be delayed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:31:54.000Z thumbnail image
  8. Check
    56 days ago
    Change Detected
    Summary
    Removed Lung cancer and MedlinePlus Genetics from the related topics section on the study page.
    Difference
    0.2%
    Check dated 2025-11-10T03:42:17.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial page.